Silver Book Fact

In a community-based pharmaceutical care services program for 194 participants in 2001, mean A1c decreased at follow-ups, with more than 50% of patients demonstrating improvements at each interval (each year for 1-5 years).

Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen. The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc. 2003; 43(2): 173-84. http://www.ncbi.nlm.nih.gov/pubmed/12688435

Reference

Title
The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program
Publication
J Am Pharm Assoc
Publication Date
2003
Authors
Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen
Volume & Issue
Volume 43, Issue 2
Pages
173-84
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Every additional dollar spent on statin therapy for diabetes patients without cardiovascular disease has produced health gains valued between $7 and $31.  
  • A study by the Diabetes Prevention Program found that the use of the drug metformin by high-risk patients reduced the risk of development of type 2 diabetes by 31%.  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • New and emerging technologies have made it easier for people with diabetes to manage their disease. Improved technology came in the form of a continuous glucose monitor, first approved by…  
  • Intensive Glycemic Control in People with Diabetes
    Intensive glycemic control in diabetics reduced their: Adjusted mean risk of DR by 76% Risk of progression by 54% Rates of laser surgery by 56% Risk of DME by 23%